Ascending aorta aneurysmal disease is common and can be complicated by dissection or rupture. There is substantial variation in individual aneurysm progression: established risk factors for an accelerated aneurysm growth rate include initial size or localization, the presence of aortic valve disease, congenital bicuspid aortic valve or connective tissue disorders.
Although there is an increased lifetime risk when the aortic diameter exceeds 6 cm, predicting aneurysm progression is nearly impossible and dissection and rupture also occur at diameters under 6 cm. The assessment of aortic hemodynamics and the presence of altered flow patterns, as well as distribution and changes in wall shear stress (WSS) and the oscillatory shear index (OSI), using 4D phase contrast cardiovascular magnetic resonance (CMR) may provide further insights in how aneurysms develop and in assessing the risk of dissection. The purpose of this study was to investigate in patients with dilated ascending aorta the flow patterns and vessel wall parameters in order to correlate these hemodynamics factors with changes in aorta size.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
41
4D Cardiac Magnetic Resonance for patients with a ascending aorta dilatation without current indication for surgery for measured parameters of ascending aorta
CHU de Saint-Etienne
Saint-Étienne-de-Montluc, Pays de la Loire Region, France
Correlation between wall shear stress (WSS) and aorta diameter in patient with dilated ascending aorta
Aorta diameter \[mm\] is assessed by 4D phase contrast cardiovascular magnetic resonance (CMR) Wall shear stress (WSS) in aorta \[Pa\] is assessed by 4D phase contrast cardiovascular magnetic resonance (CMR).
Time frame: From baseline to 1 year
Aorta parameters associated with change in aorta diameter
Aorta parameters are a composite outcome : * the oscillatory shear index (OSI) * pulse wave velocity=PWV \[m/s\] assessed by 4D phase contrast cardiovascular magnetic resonance (CMR). Aorta diameter \[mm\] is assessed by 4D phase contrast cardiovascular magnetic resonance (CMR)
Time frame: From baseline to 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.